CLINICAL_TRIALS
trial_result
· 2022-10-18
Clinical Trial Update: Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2) [Phase 3]
Summary
Phase 3 trial update for fluvoxamine in early treatment of Covid-19 (Stop Covid 2) has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Covid19, Coronavirus | Phase 3 | Status: COMPLETED | Results posted: 2022-10-18